ArticleJournal of managed care & specialty pharmacy2023

Real-world switching and discontinuation outcomes of infliximab biosimilars in patients with rheumatoid arthritis: A scoping review.

Yue Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.